Maravai LifeSciences Holdings, Inc. (MRVI) Free cash flow 2019–2025
Maravai LifeSciences Holdings, Inc. (MRVI) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$70.7MFY2025 · since FY2019: $7.0M → -$70.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$70.7M | -218.7% |
| FY2024 | -$22.2M | -136.6% |
| FY2023 | $60.7M | -88.3% |
| FY2022 | $518.9M | +46.7% |
| FY2021 | $353.7M | +179.0% |
| FY2020 | $126.8M | +1719.7% |
| FY2019 | $7.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice